You have 9 free searches left this month | for more free features.

Condition

Hepatocellular Carcinoma (2)

Overall Status

Not yet recruiting (2)

Sign in for free

Phase

phase 2 (2)

Sponsor

AbbVie (2)

Collaborator

Intervention

budigalimab (2)

livmoniplimab (2)

atezolizumab (1)

bevacizumab (1)

durvalumab (1)

lenvatinib (1)

sorafenib (1)

tremelimumab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

livmoniplimab

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Hepatocellular Carcinoma Trial (Livmoniplimab, Budigalimab, Durvalumab)

Not yet recruiting

Hepatocellular Carcinoma

Livmoniplimab
+5 more

(no location specified)

Oct 26, 2023

Hepatocellular Carcinoma Trial in Worldwide (Budigalimab, Livmoniplimab, Lenvatinib)

Not yet recruiting

Hepatocellular Carcinoma

Budigalimab
+3 more

Prescott Valley, Arizona
+58 more

Apr 10, 2023